QIAGEN has revealed the first system of a novel modular platform designed to offer laboratories a new level of flexibility, convenience and safety.
The QIA Symphony SP is the first in a series of modular instruments to be used within a broad range of molecular sample and assay applications.
According to QIAGEN, it can be integrated to automate entire workflows- from sample to result- and can be used to meet laboratory's applied testing, pharmaceutical and life science research needs.
The QIA Symphony SP allows users to load many types of samples in a variety of formats and then isolate, purify and prepare target analytes for further analysis- something which is often viewed as the most challenging step in molecular analysis.
Peer Schatz, chief executive officer of QIAGEN, said: "We are very excited to unveil our QIA Symphony platform and with it the first module: QIA Symphony SP. Standardization and process safety are key for today's labs."
"Cutting-edge technologies, innovative functions and proven QIAGEN chemistries make the QIA Symphony a truly unique solution and create a strong basis for further expansion of our already broad and leading offering of automated sample and assay technologies," he continued.
QIAGEN is a leading provider of sample and assay technologies, providing more than 500 products and technologies use to isolate DNA, RNA and proteins from any biological samples.See all the latest jobs in Science